Endurant Capital Management LP - Q1 2018 holdings

$268 Million is the total value of Endurant Capital Management LP's 69 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 56.0% .

 Value Shares↓ Weighting
AGN BuyALLERGAN PLC$17,231,000
+37.7%
102,391
+33.9%
6.44%
+68.3%
ABT BuyABBOTT LABS$16,582,000
+102.6%
276,732
+93.0%
6.19%
+147.7%
JNJ BuyJOHNSON & JOHNSON$14,623,000
+72.1%
114,111
+87.7%
5.46%
+110.3%
MDT BuyMEDTRONIC PLC$10,839,000
+15.4%
135,115
+16.2%
4.05%
+41.0%
BDX BuyBECTON DICKINSON & CO$10,625,000
+147.3%
49,030
+144.3%
3.97%
+202.3%
BSX BuyBOSTON SCIENTIFIC CORP$10,592,000
+24.7%
387,698
+13.2%
3.96%
+52.4%
UHS NewUNIVERSAL HLTH SVCS INCcl b$9,875,00083,400
+100.0%
3.69%
UNH BuyUNITEDHEALTH GROUP INC$9,717,000
+14.0%
45,408
+17.5%
3.63%
+39.3%
ANTM BuyANTHEM INC$9,690,000
+91.3%
44,105
+95.9%
3.62%
+133.9%
MRK BuyMERCK & CO INC$9,407,000
+57.6%
172,700
+62.8%
3.51%
+92.5%
DVA SellDAVITA INC$9,320,000
-39.9%
141,336
-34.2%
3.48%
-26.6%
SHPG BuySHIRE PLCsponsored adr$8,066,000
+59.0%
53,996
+65.1%
3.01%
+94.4%
WBA SellWALGREENS BOOTS ALLIANCE INC$7,871,000
-39.9%
120,223
-33.3%
2.94%
-26.5%
SYNH NewSYNEOS HEALTH INCcl a$6,830,000192,400
+100.0%
2.55%
CVS BuyCVS HEALTH CORP$6,477,000
+67.6%
104,111
+95.3%
2.42%
+104.8%
MYL BuyMYLAN N V$6,443,000
+28.1%
156,487
+31.6%
2.41%
+56.6%
HOLX SellHOLOGIC INC$6,386,000
-33.0%
170,944
-23.3%
2.39%
-18.1%
SBRA SellSABRA HEALTH CARE REIT INC$5,034,000
-57.7%
285,219
-55.0%
1.88%
-48.4%
TMO SellTHERMO FISHER SCIENTIFIC INC$4,915,000
-40.6%
23,808
-45.4%
1.84%
-27.5%
LH BuyLABORATORY CORP AMER HLDGS$4,784,000
+45.8%
29,575
+43.7%
1.79%
+78.2%
HCA NewHCA HEALTHCARE INC$4,346,00044,800
+100.0%
1.62%
MD SellMEDNAX INC$4,129,000
-57.5%
74,217
-59.2%
1.54%
-48.0%
AET SellAETNA INC NEW$4,109,000
-42.2%
24,312
-38.3%
1.54%
-29.4%
ESRX SellEXPRESS SCRIPTS HLDG CO$3,785,000
-32.1%
54,790
-26.6%
1.41%
-17.0%
GILD NewGILEAD SCIENCES INC$3,558,00047,200
+100.0%
1.33%
CI BuyCIGNA CORPORATION$3,455,000
+751.0%
20,600
+930.0%
1.29%
+941.1%
EVHC SellENVISION HEALTHCARE CORP$3,158,000
-53.4%
82,174
-58.1%
1.18%
-43.1%
CELG SellCELGENE CORP$2,855,000
-27.6%
32,000
-15.3%
1.07%
-11.6%
TVTY SellTIVITY HEALTH INC$2,411,000
-74.5%
60,819
-76.5%
0.90%
-68.8%
PTLA SellPORTOLA PHARMACEUTICALS INC$2,335,000
-55.4%
71,500
-33.6%
0.87%
-45.5%
WMGI SellWRIGHT MED GROUP N V$2,243,000
-66.9%
113,072
-63.0%
0.84%
-59.5%
PTI SellPROTEOSTASIS THERAPEUTICS IN$2,242,000
-20.7%
472,012
-2.7%
0.84%
-3.0%
BAX SellBAXTER INTL INC$2,169,000
-33.2%
33,349
-33.6%
0.81%
-18.4%
HRC SellHILL ROM HLDGS INC$2,123,000
-62.0%
24,400
-63.1%
0.79%
-53.5%
DHR SellDANAHER CORP DEL$2,082,000
-80.2%
21,265
-81.3%
0.78%
-75.9%
OXFD SellOXFORD IMMUNOTEC GLOBAL PLC$2,056,000
-74.2%
165,169
-71.0%
0.77%
-68.5%
FOLD SellAMICUS THERAPEUTICS INC$1,910,000
-35.7%
127,000
-38.5%
0.71%
-21.5%
MASI NewMASIMO CORP$1,838,00020,900
+100.0%
0.69%
CLVS SellCLOVIS ONCOLOGY INC$1,748,000
-62.0%
33,100
-51.1%
0.65%
-53.6%
PBYI SellPUMA BIOTECHNOLOGY INC$1,681,000
-43.1%
24,700
-17.4%
0.63%
-30.5%
MCK SellMCKESSON CORP$1,623,000
-85.6%
11,523
-84.0%
0.61%
-82.4%
INCY BuyINCYTE CORP$1,618,000
+130.2%
19,420
+161.7%
0.60%
+180.9%
FATE SellFATE THERAPEUTICS INC$1,516,000
-55.4%
155,344
-72.1%
0.57%
-45.6%
 ENDOLOGIX INCnote 2.250%12/1$1,498,000
+1.5%
1,541,0000.0%0.56%
+24.2%
PPH NewVANECK VECTORS ETF TRpharmaceutical$1,449,00025,500
+100.0%
0.54%
PKI BuyPERKINELMER INC$1,442,000
+109.6%
19,041
+102.5%
0.54%
+156.7%
CAH SellCARDINAL HEALTH INC$1,413,000
-77.3%
22,542
-77.9%
0.53%
-72.3%
VRX NewVALEANT PHARMACEUTICALS INTL$1,356,00085,200
+100.0%
0.51%
A NewAGILENT TECHNOLOGIES INC$1,338,00020,000
+100.0%
0.50%
DGX NewQUEST DIAGNOSTICS INC$1,304,00013,000
+100.0%
0.49%
ARRY BuyARRAY BIOPHARMA INC$1,165,000
+79.8%
71,400
+41.1%
0.44%
+119.7%
OCUL NewOCULAR THERAPEUTIX INC$1,162,000178,461
+100.0%
0.43%
ICLR NewICON PLC$992,0008,400
+100.0%
0.37%
BLCM NewBELLICUM PHARMACEUTICALS INC$947,000144,300
+100.0%
0.35%
NVRO SellNEVRO CORP$927,000
-50.2%
10,701
-60.3%
0.35%
-39.2%
TFX NewTELEFLEX INC$918,0003,600
+100.0%
0.34%
JAZZ BuyJAZZ PHARMACEUTICALS PLC$770,000
+15.4%
5,100
+3.0%
0.29%
+41.2%
REGN SellREGENERON PHARMACEUTICALS$758,000
-64.0%
2,200
-60.7%
0.28%
-56.0%
RDUS SellRADIUS HEALTH INC$686,000
-47.8%
19,100
-53.9%
0.26%
-36.3%
XRAY NewDENTSPLY SIRONA INC$664,00013,200
+100.0%
0.25%
QGEN NewQIAGEN NV$662,00020,500
+100.0%
0.25%
ZGNX SellZOGENIX INC$653,000
-18.5%
16,300
-18.5%
0.24%
-0.4%
ALRN SellAILERON THERAPEUTICS INC$615,000
-32.1%
75,697
-12.0%
0.23%
-17.0%
MDCO SellMEDICINES CO$560,000
-50.3%
17,000
-58.7%
0.21%
-39.2%
VKTX NewVIKING THERAPEUTICS INC$520,000119,100
+100.0%
0.19%
RETA NewREATA PHARMACEUTICALS INCcl a$513,00025,000
+100.0%
0.19%
AVDL NewAVADEL PHARMACEUTICALS PLCsponsored adr$406,00055,700
+100.0%
0.15%
AKTX SellAKARI THERAPEUTICS PLCsponsored adr$359,000
-58.8%
197,497
-1.8%
0.13%
-49.6%
ANAB SellANAPTYSBIO INC$326,000
-66.6%
3,130
-67.7%
0.12%
-59.2%
DRNA ExitDICERNA PHARMACEUTICALS INC$0-18,837
-100.0%
-0.05%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-10,300
-100.0%
-0.08%
SPRO ExitSPERO THERAPEUTICS INC$0-31,100
-100.0%
-0.11%
APLS ExitAPELLIS PHARMACEUTICALS INC$0-17,600
-100.0%
-0.12%
ASMB ExitASSEMBLY BIOSCIENCES INC$0-9,500
-100.0%
-0.13%
OMED ExitONCOMED PHARMACEUTICALS INC$0-139,100
-100.0%
-0.17%
INSM ExitINSMED INC$0-22,910
-100.0%
-0.22%
BMRN ExitBIOMARIN PHARMACEUTICAL INC$0-10,100
-100.0%
-0.28%
VCRA ExitVOCERA COMMUNICATIONS INC$0-32,500
-100.0%
-0.30%
IMGN ExitIMMUNOGEN INC$0-210,800
-100.0%
-0.41%
EW ExitEDWARDS LIFESCIENCES CORP$0-12,216
-100.0%
-0.42%
TCMD ExitTACTILE SYS TECHNOLOGY INC$0-50,900
-100.0%
-0.45%
ASND ExitASCENDIS PHARMA A Ssponsored adr$0-37,828
-100.0%
-0.46%
ARA ExitAMERICAN RENAL ASSOCIATES HO$0-89,129
-100.0%
-0.47%
HUM ExitHUMANA INC$0-6,800
-100.0%
-0.52%
MEDP ExitMEDPACE HLDGS INC$0-63,100
-100.0%
-0.70%
AERI ExitAERIE PHARMACEUTICALS INC$0-45,366
-100.0%
-0.83%
SRPT ExitSAREPTA THERAPEUTICS INC$0-48,800
-100.0%
-0.83%
SYK ExitSTRYKER CORP$0-17,867
-100.0%
-0.85%
ENTL ExitENTELLUS MED INC$0-189,268
-100.0%
-1.41%
BIIB ExitBIOGEN INC$0-15,399
-100.0%
-1.50%
INCR ExitINC RESH HLDGS INCcl a$0-112,900
-100.0%
-1.50%
ABC ExitAMERISOURCEBERGEN CORP$0-55,240
-100.0%
-1.55%
BBH ExitVANECK VECTORS ETF TRbiotech etf$0-49,899
-100.0%
-1.90%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LABORATORY CORP AMER HLDGS31Q2 20238.7%
ELEVANCE HEALTH INC29Q3 20238.8%
BECTON DICKINSON & CO28Q2 20239.8%
MCKESSON CORP27Q1 20234.4%
CENCORA INC26Q3 20235.9%
HOLOGIC INC24Q3 20237.5%
JOHNSON & JOHNSON24Q4 20215.5%
ZIMMER HLDGS INC23Q3 20237.5%
BOSTON SCIENTIFIC CORP22Q3 20235.5%
DAVITA INC22Q1 20214.9%

View Endurant Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Endurant Capital Management LP Q1 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AZIYO BIOLOGICS, INC.March 21, 2023576,2534.9%
Oxford Immunotec Global PLCSold outFebruary 17, 202100.0%

View Endurant Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-10
13F-HR2024-02-14
13F-HR2023-11-14
SC 13D/A2023-09-08
13F-HR2023-08-14
3/A2023-05-24
13F-HR2023-05-15
32023-05-15
SC 13D2023-05-15
SC 13G/A2023-03-21

View Endurant Capital Management LP's complete filings history.

Compare quarters

Export Endurant Capital Management LP's holdings